Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Pathol Res Pract. 2019 Aug;215(8):152468. doi: 10.1016/j.prp.2019.152468. Epub 2019 May 24.
Hepatocellular carcinoma (HCC) is one of the most malignant cancers around the world. However, the early biomarkers for its detection and treatment are limited currently. Exosomes, classified as intercellular messenger shuttling their cargoes between cells, regulate cell differentiation and tissue development. They contain messenger RNA (mRNA), microRNA (miRNA), long non-coding RNA (lncRNA), circular RNA (circRNA), proteins, lipids and transcription factors. Therefore, exosomes play a crucial role in the development of HCC. In this review, we highlight the exosomal cargoes which could serve as biomarkers for the prediction and diagnosis of HCC. Exosomes are involved in metastases of HCC and they show great potential in immunotherapy and drug resistance mechanism. In summary, exosome suggests new clues in clinical application of HCC.
肝细胞癌 (HCC) 是全球最恶性的癌症之一。然而,目前用于其检测和治疗的早期生物标志物有限。外泌体被归类为细胞间信使,它们在细胞之间传递货物,调节细胞分化和组织发育。它们包含信使 RNA(mRNA)、微小 RNA(miRNA)、长非编码 RNA(lncRNA)、环状 RNA(circRNA)、蛋白质、脂质和转录因子。因此,外泌体在 HCC 的发展中起着至关重要的作用。在这篇综述中,我们强调了可以作为 HCC 预测和诊断生物标志物的外泌体货物。外泌体参与 HCC 的转移,它们在免疫治疗和耐药机制中显示出巨大的潜力。总之,外泌体为 HCC 的临床应用提供了新的线索。